Lineage Cell Therapeutics, Inc.
LCTXNYSECIK 876343HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | 1.2Revenue, Q3 FY2023, three months to 2023-09-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 2.1Revenue, Q4 FY2023, three months to 2023-12-31$2.1m. XBRL concept us-gaap:Revenues. 10-K filed 2024-03-07, accession 0000950170-24-027988.Report this figure | 1.4Revenue, Q1 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 1.4Revenue, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | 3.8Revenue, Q3 FY2024, three months to 2024-09-30$3.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 2.9Revenue, Q4 FY2024, three months to 2024-12-31$2.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | 1.5Revenue, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 2.8Revenue, Q2 FY2025, three months to 2025-06-30$2.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 3.7Revenue, Q3 FY2025, three months to 2025-09-30$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 6.6Revenue, Q4 FY2025, three months to 2025-12-31$6.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | 1.7Revenue, Q1 FY2026, three months to 2026-03-31$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 1.1Revenue, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Cost of revenue | $m | 0.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$169.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 0.3Cost of revenue, Q4 FY2023, three months to 2023-12-31$256.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-10, accession 0000950170-25-036309. Derived: 12-month figure less the 9-month figure.Report this figure | 0.1Cost of revenue, Q1 FY2024, three months to 2024-03-31$98.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 0.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$44.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-08-08, accession 0000950170-24-094004.Report this figure | 0.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$38.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 0.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$154.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-10, accession 0000950170-25-036309. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$36.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | 1.1Gross profit, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2023-11-09, accession 0001493152-23-040058.Report this figure | 1.8Gross profit, Q4 FY2023, three months to 2023-12-31$1.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-07, accession 0000950170-24-027988. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | 3.7Research and development, Q3 FY2023, three months to 2023-09-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 3.9Research and development, Q4 FY2023, three months to 2023-12-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-10, accession 0000950170-25-036309. Derived: 12-month figure less the 9-month figure.Report this figure | 3.0Research and development, Q1 FY2024, three months to 2024-03-31$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 2.9Research and development, Q2 FY2024, three months to 2024-06-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | 3.2Research and development, Q3 FY2024, three months to 2024-09-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 3.4Research and development, Q4 FY2024, three months to 2024-12-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | 3.1Research and development, Q1 FY2025, three months to 2025-03-31$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 3.1Research and development, Q2 FY2025, three months to 2025-06-30$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 3.3Research and development, Q3 FY2025, three months to 2025-09-30$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 8.2Research and development, Q4 FY2025, three months to 2025-12-31$8.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | 4.2Research and development, Q1 FY2026, three months to 2026-03-31$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 4.8Research and development, Q2 FY2026, three months to 2026-06-30$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Operating income | $m | (6.7)Operating income, Q3 FY2023, three months to 2023-09-30−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | (6.4)Operating income, Q4 FY2023, three months to 2023-12-31−$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-07, accession 0000950170-24-027988.Report this figure | (6.7)Operating income, Q1 FY2024, three months to 2024-03-31−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | (5.9)Operating income, Q2 FY2024, three months to 2024-06-30−$5.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | (3.8)Operating income, Q3 FY2024, three months to 2024-09-30−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | (5.1)Operating income, Q4 FY2024, three months to 2024-12-31−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | (6.5)Operating income, Q1 FY2025, three months to 2025-03-31−$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | (19.8)Operating income, Q2 FY2025, three months to 2025-06-30−$19.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | (3.8)Operating income, Q3 FY2025, three months to 2025-09-30−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | (6.5)Operating income, Q4 FY2025, three months to 2025-12-31−$6.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | (7.6)Operating income, Q1 FY2026, three months to 2026-03-31−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | (8.9)Operating income, Q2 FY2026, three months to 2026-06-30−$8.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Income tax | $m | 0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-10, accession 0000950170-25-036309. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-09, accession 0000950170-24-056998.Report this figure | 0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-08, accession 0000950170-24-094004.Report this figure | 0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | (7.1)Net income, Q3 FY2023, three months to 2023-09-30−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | (4.8)Net income, Q4 FY2023, three months to 2023-12-31−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-07, accession 0000950170-24-027988.Report this figure | (6.5)Net income, Q1 FY2024, three months to 2024-03-31−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | (5.8)Net income, Q2 FY2024, three months to 2024-06-30−$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | (3.0)Net income, Q3 FY2024, three months to 2024-09-30−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | (3.3)Net income, Q4 FY2024, three months to 2024-12-31−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | (4.1)Net income, Q1 FY2025, three months to 2025-03-31−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | (30.5)Net income, Q2 FY2025, three months to 2025-06-30−$30.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | (29.8)Net income, Q3 FY2025, three months to 2025-09-30−$29.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 0.9Net income, Q4 FY2025, three months to 2025-12-31$851.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | (4.8)Net income, Q1 FY2026, three months to 2026-03-31−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 1.5Net income, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Diluted EPS | $ per share | (0.04)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | (0.03)Diluted EPS, Q4 FY2023, three months to 2023-12-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-07, accession 0000950170-24-027988.Report this figure | (0.04)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | (0.03)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | (0.02)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | not reported | (0.02)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | (0.13)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | (0.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | not reported | (0.03)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | (0.03)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Basic EPS | $ per share | (0.04)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | (0.03)Basic EPS, Q4 FY2023, three months to 2023-12-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-03-07, accession 0000950170-24-027988.Report this figure | (0.04)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | (0.03)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | (0.02)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | not reported | (0.02)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | (0.13)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | (0.13)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | not reported | (0.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 0.01Basic EPS, Q2 FY2026, three months to 2026-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 31.5Cash and equivalents, Q3 FY2023, at 2023-09-30$31.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 35.4Cash and equivalents, FY2023, at 2023-12-31$35.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-10, accession 0000950170-25-036309.Report this figure | 43.6Cash and equivalents, Q1 FY2024, at 2024-03-31$43.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 29.6Cash and equivalents, Q2 FY2024, at 2024-06-30$29.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | 27.8Cash and equivalents, Q3 FY2024, at 2024-09-30$27.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 45.8Cash and equivalents, FY2024, at 2024-12-31$45.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-093992.Report this figure | 47.9Cash and equivalents, Q1 FY2025, at 2025-03-31$47.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 42.3Cash and equivalents, Q2 FY2025, at 2025-06-30$42.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 40.5Cash and equivalents, Q3 FY2025, at 2025-09-30$40.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 40.8Cash and equivalents, FY2025, at 2025-12-31$40.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 35.9Cash and equivalents, Q1 FY2026, at 2026-03-31$35.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 37.4Cash and equivalents, Q2 FY2026, at 2026-06-30$37.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Current assets | $m | 43.5Current assets, Q3 FY2023, at 2023-09-30$43.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001493152-23-040058.Report this figure | 38.4Current assets, FY2023, at 2023-12-31$38.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-10, accession 0000950170-25-036309.Report this figure | 45.7Current assets, Q1 FY2024, at 2024-03-31$45.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056998.Report this figure | 40.4Current assets, Q2 FY2024, at 2024-06-30$40.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094004.Report this figure | 34.4Current assets, Q3 FY2024, at 2024-09-30$34.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 51.0Current assets, FY2024, at 2024-12-31$51.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-093992.Report this figure | 50.0Current assets, Q1 FY2025, at 2025-03-31$50.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 43.8Current assets, Q2 FY2025, at 2025-06-30$43.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | 42.3Current assets, Q3 FY2025, at 2025-09-30$42.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 59.2Current assets, FY2025, at 2025-12-31$59.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 56.2Current assets, Q1 FY2026, at 2026-03-31$56.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 53.0Current assets, Q2 FY2026, at 2026-06-30$53.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Total assets | $m | 106Total assets, Q3 FY2023, at 2023-09-30$106.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001493152-23-040058.Report this figure | 101Total assets, FY2023, at 2023-12-31$101.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-10, accession 0000950170-25-036309.Report this figure | 108Total assets, Q1 FY2024, at 2024-03-31$108.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056998.Report this figure | 103Total assets, Q2 FY2024, at 2024-06-30$102.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094004.Report this figure | 96.6Total assets, Q3 FY2024, at 2024-09-30$96.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 113Total assets, FY2024, at 2024-12-31$113.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-093992.Report this figure | 112Total assets, Q1 FY2025, at 2025-03-31$111.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 90.8Total assets, Q2 FY2025, at 2025-06-30$90.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | 89.6Total assets, Q3 FY2025, at 2025-09-30$89.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 113Total assets, FY2025, at 2025-12-31$112.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 110Total assets, Q1 FY2026, at 2026-03-31$109.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 106Total assets, Q2 FY2026, at 2026-06-30$106.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Current liabilities | $m | 15.9Current liabilities, Q3 FY2023, at 2023-09-30$15.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001493152-23-040058.Report this figure | 18.0Current liabilities, FY2023, at 2023-12-31$18.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-10, accession 0000950170-25-036309.Report this figure | 16.9Current liabilities, Q1 FY2024, at 2024-03-31$16.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056998.Report this figure | 15.3Current liabilities, Q2 FY2024, at 2024-06-30$15.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094004.Report this figure | 13.9Current liabilities, Q3 FY2024, at 2024-09-30$13.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 14.0Current liabilities, FY2024, at 2024-12-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-093992.Report this figure | 13.1Current liabilities, Q1 FY2025, at 2025-03-31$13.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 10.8Current liabilities, Q2 FY2025, at 2025-06-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | 9.4Current liabilities, Q3 FY2025, at 2025-09-30$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 11.4Current liabilities, FY2025, at 2025-12-31$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 8.1Current liabilities, Q1 FY2026, at 2026-03-31$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 8.0Current liabilities, Q2 FY2026, at 2026-06-30$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Total liabilities | $m | 39.5Total liabilities, Q3 FY2023, at 2023-09-30$39.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001493152-23-040058.Report this figure | 39.0Total liabilities, FY2023, at 2023-12-31$39.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-10, accession 0000950170-25-036309.Report this figure | 37.5Total liabilities, Q1 FY2024, at 2024-03-31$37.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056998.Report this figure | 35.9Total liabilities, Q2 FY2024, at 2024-06-30$35.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094004.Report this figure | 31.8Total liabilities, Q3 FY2024, at 2024-09-30$31.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 36.2Total liabilities, FY2024, at 2024-12-31$36.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-093992.Report this figure | 34.1Total liabilities, Q1 FY2025, at 2025-03-31$34.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 43.7Total liabilities, Q2 FY2025, at 2025-06-30$43.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | 68.8Total liabilities, Q3 FY2025, at 2025-09-30$68.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 69.2Total liabilities, FY2025, at 2025-12-31$69.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 56.8Total liabilities, Q1 FY2026, at 2026-03-31$56.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 46.4Total liabilities, Q2 FY2026, at 2026-06-30$46.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
| Shareholders' equity | $m | 68.1Shareholders' equity, Q3 FY2023, at 2023-09-30$68.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0001493152-23-040058.Report this figure | 63.4Shareholders' equity, FY2023, at 2023-12-31$63.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-10, accession 0000950170-25-036309.Report this figure | 72.4Shareholders' equity, Q1 FY2024, at 2024-03-31$72.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-09, accession 0000950170-24-056998.Report this figure | 68.3Shareholders' equity, Q2 FY2024, at 2024-06-30$68.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-08, accession 0000950170-24-094004.Report this figure | 66.2Shareholders' equity, Q3 FY2024, at 2024-09-30$66.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-127077.Report this figure | 78.4Shareholders' equity, FY2024, at 2024-12-31$78.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-093992.Report this figure | 79.0Shareholders' equity, Q1 FY2025, at 2025-03-31$79.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 48.4Shareholders' equity, Q2 FY2025, at 2025-06-30$48.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0000950170-25-107333.Report this figure | 22.0Shareholders' equity, Q3 FY2025, at 2025-09-30$22.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269599.Report this figure | 44.5Shareholders' equity, FY2025, at 2025-12-31$44.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure | 53.9Shareholders' equity, Q1 FY2026, at 2026-03-31$53.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 60.9Shareholders' equity, Q2 FY2026, at 2026-06-30$60.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338064.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $k | (5,037)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-127077. Derived: 9-month figure less the 6-month figure.Report this figure | (6,019)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-10, accession 0000950170-25-036309. Derived: 12-month figure less the 9-month figure.Report this figure | (5,783)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | (5,176)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107333. Derived: 6-month figure less the 3-month figure.Report this figure | (5,787)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269599. Derived: 9-month figure less the 6-month figure.Report this figure | (6,346)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | (4,886)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | (5,539)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338064. Derived: 6-month figure less the 3-month figure.Report this figure | (3,616)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269599. Derived: 9-month figure less the 6-month figure.Report this figure | (4,878)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | (8,078)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | (7,244)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338064. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $k | 139Capital expenditure, Q3 FY2023, three months to 2023-09-30$139.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-127077. Derived: 9-month figure less the 6-month figure.Report this figure | 91.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$91.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-10, accession 0000950170-25-036309. Derived: 12-month figure less the 9-month figure.Report this figure | 38.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$38.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070378.Report this figure | 50.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107333. Derived: 6-month figure less the 3-month figure.Report this figure | 112Capital expenditure, Q3 FY2024, three months to 2024-09-30$112.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269599. Derived: 9-month figure less the 6-month figure.Report this figure | 365Capital expenditure, Q4 FY2024, three months to 2024-12-31$365.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | 97.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$97.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 14.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338064. Derived: 6-month figure less the 3-month figure.Report this figure | 12.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269599. Derived: 9-month figure less the 6-month figure.Report this figure | 399Capital expenditure, Q4 FY2025, three months to 2025-12-31$399.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-093992. Derived: 12-month figure less the 9-month figure.Report this figure | 55.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$55.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219479.Report this figure | 108Capital expenditure, Q2 FY2026, three months to 2026-06-30$108.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338064. Derived: 6-month figure less the 3-month figure.Report this figure |
Shares
| Line item | Unit | Q3 FY20222022-09-30 | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 170 | 170 | 171 | 175 | 183 | 189 | 189 | 226 | 228 | 229 | 261 | 261 |
Shares outstanding: 252.91m at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. Listed shows no prices and gives no investment advice.